Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 765

    1.

    The efficacy of acarbose in the treatment of patients with non-insulin-dependent diabetes mellitus. A multicenter controlled clinical trial.

    Chiasson JL, Josse RG, Hunt JA, Palmason C, Rodger NW, Ross SA, Ryan EA, Tan MH, Wolever TM.

    Ann Intern Med. 1994 Dec 15;121(12):928-35.PMID: 7734015 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Acarbose in NIDDM patients with poor control on conventional oral agents. A 24-week placebo-controlled study.

    Lam KS, Tiu SC, Tsang MW, Ip TP, Tam SC.

    Diabetes Care. 1998 Jul;21(7):1154-8.PMID: 9653611 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Acarbose for the treatment of type II diabetes: the results of a Canadian multi-centre trial.

    Josse RG.

    Diabetes Res Clin Pract. 1995 Aug;28 Suppl:S167-72. Erratum in: Diabetes Res Clin Pract 1995 Sep;29(3):215. PMID: 8529510 [PubMed - indexed for MEDLINE]Related articles

    5.

    Long-term efficacy and safety of acarbose in the treatment of obese subjects with non-insulin-dependent diabetes mellitus.

    Coniff RF, Shapiro JA, Seaton TB.

    Arch Intern Med. 1994 Nov 14;154(21):2442-8.PMID: 7979840 [PubMed - indexed for MEDLINE]Related articles

    7.

    Efficacy and safety of acarbose in metformin-treated patients with type 2 diabetes.

    Rosenstock J, Brown A, Fischer J, Jain A, Littlejohn T, Nadeau D, Sussman A, Taylor T, Krol A, Magner J.

    Diabetes Care. 1998 Dec;21(12):2050-5.PMID: 9839093 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Therapeutic potentials of acarbose as first-line drug in NIDDM insufficiently treated with diet alone.

    Hanefeld M, Fischer S, Schulze J, Spengler M, Wargenau M, Schollberg K, Fücker K.

    Diabetes Care. 1991 Aug;14(8):732-7.PMID: 1954810 [PubMed - indexed for MEDLINE]Related articles

    9.

    Effects of alpha-glucosidase inhibitor (acarbose) combined with sulfonylurea or sulfonylurea and metformin in treatment of non-insulin-dependent diabetes mellitus.

    Vannasaeng S, Ploybutr S, Nitiyanant W, Peerapatdit T, Vichayanrat A.

    J Med Assoc Thai. 1995 Nov;78(11):578-85.PMID: 8576667 [PubMed - indexed for MEDLINE]Related articles

    12.

    Reduction of glycosylated hemoglobin and postprandial hyperglycemia by acarbose in patients with NIDDM. A placebo-controlled dose-comparison study.

    Coniff RF, Shapiro JA, Robbins D, Kleinfield R, Seaton TB, Beisswenger P, McGill JB.

    Diabetes Care. 1995 Jun;18(6):817-24.PMID: 7555508 [PubMed - indexed for MEDLINE]Related articles

    13.

    A double-blind placebo-controlled trial evaluating the safety and efficacy of acarbose for the treatment of patients with insulin-requiring type II diabetes.

    Coniff RF, Shapiro JA, Seaton TB, Hoogwerf BJ, Hunt JA.

    Diabetes Care. 1995 Jul;18(7):928-32.PMID: 7555551 [PubMed - indexed for MEDLINE]Related articles

    14.

    A comparison of acarbose versus metformin as an adjuvant therapy in sulfonylurea-treated NIDDM patients.

    Bayraktar M, Van Thiel DH, Adalar N.

    Diabetes Care. 1996 Mar;19(3):252-4.PMID: 8742572 [PubMed - indexed for MEDLINE]Related articles

    16.

    Small weight loss on long-term acarbose therapy with no change in dietary pattern or nutrient intake of individuals with non-insulin-dependent diabetes.

    Wolever TM, Chiasson JL, Josse RG, Hunt JA, Palmason C, Rodger NW, Ross SA, Ryan EA, Tan MH.

    Int J Obes Relat Metab Disord. 1997 Sep;21(9):756-63.PMID: 9376887 [PubMed - indexed for MEDLINE]Related articles

    17.

    Efficacy of 24-week monotherapy with acarbose, metformin, or placebo in dietary-treated NIDDM patients: the Essen-II Study.

    Hoffmann J, Spengler M.

    Am J Med. 1997 Dec;103(6):483-90.PMID: 9428831 [PubMed - indexed for MEDLINE]Related articles

    18.

    Efficacy and safety of acarbose in insulin-treated patients with type 2 diabetes.

    Kelley DE, Bidot P, Freedman Z, Haag B, Podlecki D, Rendell M, Schimel D, Weiss S, Taylor T, Krol A, Magner J.

    Diabetes Care. 1998 Dec;21(12):2056-61.PMID: 9839094 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Clinical experience with acarbose: results of a Canadian multicentre study.

    Rodger NW, Chiasson JL, Josse RG, Hunt JA, Palmason C, Ross SA, Ryan EA, Tan MH, Wolever TM.

    Clin Invest Med. 1995 Aug;18(4):318-24.PMID: 8549019 [PubMed - indexed for MEDLINE]Related articles

    20.

    Efficacy and tolerability of acarbose in Asian patients with type 2 diabetes inadequately controlled with diet and sulfonylureas.

    Lin BJ, Wu HP, Huang HS, Juang JH, Sison A, bin Abdul Kadir DK, Cho CG, Sridama W; Writing Group for the Asian Study of Acarbose with Sulfonylureas.

    J Diabetes Complications. 2003 Jul-Aug;17(4):179-85. Erratum in: J Diabetes Complications. 2005 Jul-Aug;19(4):following 246. Huarng, Jyuhn [corrected to Juang, Jyuhn-Huarng]. PMID: 12810240 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data